A RANDOMIZED CONTROLLED TRIAL OF STRICT GLYCEMIC CONTROL AND TERTIARYLEVEL OBSTETRIC CARE VERSUS ROUTINE OBSTETRIC CARE IN THE MANAGEMENT OF GESTATIONAL DIABETES - A PILOT-STUDY
P. Garner et al., A RANDOMIZED CONTROLLED TRIAL OF STRICT GLYCEMIC CONTROL AND TERTIARYLEVEL OBSTETRIC CARE VERSUS ROUTINE OBSTETRIC CARE IN THE MANAGEMENT OF GESTATIONAL DIABETES - A PILOT-STUDY, American journal of obstetrics and gynecology, 177(1), 1997, pp. 190-195
OBJECTIVES: The purpose of this study was to determine whether strict
maternal glycemic control for the treatment of gestational diabetes le
ssened the risk of fetal macrosomia, birth trauma, neonatal hypoglycem
ia, and operative delivery. The aim of the pilot study was to prepare
for a multicenter trial by assessing patient acceptance of the study,
by determining realistic accrual rates, and by detecting any major adv
erse outcomes in the control group that received routine obstetric car
e. STUDY DESIGN: The study was a prospective randomized controlled tri
al comparing fetal-neonatal and maternal outcomes in 300 women with ge
stational diabetes. Women randomized to the treatment arm were managed
by strict glycemic control and tertiary level obstetric care, and wom
en in the control arm received routine obstetric care. RESULTS: Three
hundred women with gestational diabetes mellitus were studied. There w
as no difference in maternal age, weight, or length of gestation betwe
en groups. The treatment mean birth weight was 3437 +/- 575 gm compare
d with 3544 +/- 601 gm in the control group, a difference of 107 gm (n
ot significant). Macrosomia rates were similar. There was no birth tra
uma in either group. The frequency of neonatal hypoglycemia and other
metabolic complications was the same. The mode of delivery also showed
similar patterns. The treatment group had significantly lower prepran
dial and postprandial glucose levels by 32 weeks' gestation; which con
tinued to term. CONCLUSION: This pilot study suggests that intensive t
reatment of gestational diabetes mellitus may have little effect on bi
rth weight, birth trauma, operative delivery, or neonatal metabolic di
sorders. It has demonstrated the safety of proceeding to a multicenter
trial of sufficient sample size to confirm these findings.